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Our understanding of reactive oxygen species (ROS)—a
group of highly reactive chemicals containing oxygen—has
changed in the last few years from ROS as just harmful
substances to crucial intra- and extracellular messengers as
well as important regulators controlling a wide spectrum
of signaling pathways. Nevertheless, there are still many
uninvestigated points and open questions regarding ROS,
especially in pathophysiology. Delicately controlled ROS
homeostasis is critical for maintaining normal cell functions
and any disruption in the oxidation-antioxidation balance
leads to oxidative stress associated with a wide spectrum of
human disorders such as chronic inflammation, age-related
diseases, and cancers. In health, the intracellular ROS level is
tightly controlled by various antioxidants. In contrast, cancer
cells have an abnormally high level of ROSdue to an increased
ROS production and/or impaired ROS detoxification that
can damage intracellular macromolecules such as nucleic
acids, proteins, and lipids. ElevatedROSproduction in cancer
cells may result from an aberrant metabolic activity, mito-
chondrial dysfunction, disturbed cellular signaling, oncogene
activity, and interactionwith tumor infiltrating immune cells.
The ultimate purpose of this special issue is to publish
high-quality research communications as well as review
articles dedicated to the role of ROS in cancer biology,
anticancer therapy, and related topics. Five articles published
in this special issue are devoted to reactive oxygen species in
cancer biology. Presently, it is rather well known that H
2
O
2
has the opposite effects on cancer cell proliferation depending
on its concentration and cancer type. G. Vilema-Enriquez et
al. in their article “Molecular andCellular Effects ofHydrogen
Peroxide on Human Lung Cancer Cells: Potential Thera-
peutic Implications” review effects of hydrogen peroxide on
human lung cancer.The authors discussed effects of H
2
O
2
on
migration and invasion, calcium release, and othermolecular
features of cancer cells. Furthermore, they describe the
link between hydrogen peroxide and inflammation. Finally,
the authors hypothesize that novel therapeutic approaches
against lung cancer may be based on the use of H
2
O
2
. Y.-C.
Hung et al. in their review “Roles of Reactive Oxygen Species
in Anticancer Therapy with Salvia miltiorrhiza Bunge” deal
with Danshen as a drug of the traditional Chinese medicine
and provide a systematic review of its antioxidant capacity
and potential anticancer effects. Moreover, they conclude
that based on the existed preclinical data this drug may be
pipelined in clinical trials. A research paper by W. Li et
al. (“Hyperglycemia Promotes the Epithelial-Mesenchymal
Transition of Pancreatic Cancer via Hydrogen Peroxide”)
deals with hyperglycemia in pancreatic cancer cells. The
authors succeeded in finding the link between hyperglycemia
and epithelial-mesenchymal transition through the produc-
tion of hydrogen peroxide. Another research report on
breast cancer of D. M. Badr et al. (“The Combination of 𝛼-
Tocopheryl Succinate and Sodium Selenite on Breast Cancer:
A Merit or a Demerit?”) shows in vitro and in vivo that
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sodium selenite antagonizes effects of 𝛼-tocopheryl succinate
on apoptosis induction in cancer cells via inhibition of
oxidative stress. An intriguing review came from France,
authored by M. Assi and A. Re´billard, and was devoted to
the problem of cachexia in cancer patients (“The Janus-Faced
Role ofAntioxidants inCancerCachexia:New Insights on the
Established Concepts”). As regulators of catabolic pathways
ROS are involved in muscle atrophy in cachectic cancer
patients, the authors summarize and discuss contradictory
data on the effects of antioxidants in such patients.
The next topic highlighted in this issue is devoted to ROS
in tumor immunology. A review by X. Chen et al. (“Reactive
Oxygen Species Regulate T Cell Immune Response in the
Tumor Microenvironment”) gives readers an overview of
ROS in the tumor microenvironment and especially in the
tumor-induced immunosuppression. The authors, based on
improvement of anticancer T cell response, consider an
antioxidant treatment as a promising option for cancer
therapy. A. Scala et al. in their research article “Alterations in
Red Blood Cell Functionality Induced by an Indole Scaffold
Containing a Y-Iminodiketo Moiety: Potential Antiprolifera-
tive Conditions” deal with a prediction of the antiproliferative
effects of heterocyclic scaffolds, which could be important for
development of new therapeutic approaches against cancer.
A research article by M. Weniger et al. (“The Analgesic
Effect of the Mitochondria-Targeted Antioxidant SkQ1 in
Pancreatic Inflammation”) considers pancreatitis as a main
risk factor for pancreatic cancer. The authors show an unex-
pected analgesic effect of the new antioxidant SkQ1 during
pancreatic inflammation.The last article from this issue deals
with the oxidative stress in cancer-prone diseases in pediatric
age. S. Perrone et al. in “Oxidative Stress in Cancer-Prone
Genetic Diseases in Pediatric Age:The Role ofMitochondrial
Dysfunction” review recent literature on such diseases and
discuss molecular mechanisms of oxidative stress associ-
ated with mitochondrial dysfunction. They conclude that
mitochondria-targeted medicines could be applied into the
clinics to improve the quality of life of patients with cancer-
prone genetic diseases.
Summarizing, the wide spectrum of review and research
articles presented in this issue provides recent interesting
data on ROS in the context of cancer biology and anticancer
therapy.
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